May 15, 2018 / 12:39 PM / 11 days ago

BRIEF-Aevi Genomic Medicine Q1 Loss Per Share $0.15

May 15 (Reuters) - Aevi Genomic Medicine Inc:

* AEVI GENOMIC MEDICINE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 LOSS PER SHARE $0.15

* Q1 EARNINGS PER SHARE VIEW $-0.14 — THOMSON REUTERS I/B/E/S

* CASH AND CASH EQUIVALENTS OF $26.52 MILLION AT MARCH 31, 2018, COMPARED TO $33.73 MILLION AS OF DECEMBER 31, 2017

* EXPECTS CURRENT CASH BALANCE TO FUND OPERATIONS INTO EARLY 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below